Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
- Status
- COMPLETED
- Phase
- PHASE3
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
- Status
- TERMINATED
- Phase
- PHASE2
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2